LMNA and cardiomyopathy: Finally, Salvarani et al. used CRISPR-Cas9 editing tool to decipher the conduction abnormalities associated with LMNA-cardiomyopathies of iPSC-derived cardiomyocytes harboring LMNA p.Lys219Thr (LMNA-K219T) mutation.